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ABSTRACT
Fructose is commonly used as a taste enhancer in many processed foods. Excessive fructose consumption is highly 
associated with obesity and development of cancer particularly prostate cancer. This study aimed to investigate the 
biochemical and molecular changes in the prostate tissue of rats treated with 20% fructose for six months. A total 
of 18 rats weighted 200-250 g were divided into two groups, where each group consisted of 9 rats. Control group 
is given normal diet, while the treated group was given normal diet and 20% fructose in drinking water. After six 
months of treatment, both groups were sacrificed for further analysis. Body weight, blood pressure and glucose were 
measured. Lipid profiles were determined using quantitative colorimetric assay. Transcripts level of 11β-hydroxysteroid 
dehydrogenase type 1 (11β-HSD1), leptin (LEP), angiopoietin 1 (ANGPT1), microRNA (miR)-34a, miR-10b and miR-
192 were determined using quantitative PCR, while the protein levels of 11β-HSD1 and leptin were determined using 
ELISA. The results showed that 20% fructose diet significantly increased blood glucose level as compared to the control 
(p<0.05). The transcript levels of LEP and miR-192 were significantly lower in the fructose-treated group as compared 
to the control (p<0.05). There was a significant linear relationship between prostate LEP and serum LDL/VLDL level 
as well as between the level of prostate LEP and serum total cholesterol level (p<0.05). Thus, our results showed that 
chronic consumption of fructose could down-regulate LEP and miR-192 expression in prostate tissue, and promote 
higher accumulation of fat in the tissue. Additionally, downregulation of miR-192 has been reported to be associated 
with the pathogenesis of prostate cancer. Thus, it can be concluded that long-term fructose diet leads to higher blood 
glucose level and down-regulation of LEP and miR-192 expression in prostate tissue. 
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ABSTRAK
Fruktosa lazimnya digunakan sebagai penambah perisa dalam kebanyakan makanan yang diproses. Pengambilan 
fruktosa secara berlebihan sangat berkait rapat dengan  keobesan dan pembentukan kanser terutamanya kanser 
prostat. Kajian ini bertujuan untuk mengkaji perubahan biokimia dan molekul dalam tisu prostat tikus yang dirawat 
dengan fruktosa 20% selama enam bulan. Sejumlah 18 ekor tikus dengan berat 200-250 g dibahagikan kepada dua 
kumpulan dengan setiap kumpulan mengandungi 9 ekor tikus. Kumpulan kawalan diberi diet normal, sementara 
kumpulan rawatan diberi diet normal dan 20% fruktosa dalam minuman. Selepas enam bulan rawatan, kedua-
dua kumpulan dikorbankan untuk analisis selanjutnya. Berat tubuh, tekanan darah dan aras glukosa diukur. Profil 
lipid ditentukan menggunakan asai kolorimetrik kuantitatif. Aras transkripsi 11β-hidroksisteroid dehidrogenase 
jenis 1 (11β-HSD1), leptin (LEP), angiopoietin 1 (ANGPT1), mikroRNA (miR)-34a, miR-10b dan miR-192 ditentukan 
menggunakan kuantitatif PCR, sementara aras protein 11β-HSD1 dan leptin ditentukan menggunakan ELISA. Keputusan 
menunjukkan bahawa diet fruktosa 20% secara signifikan meningkatkan aras glukosa darah berbanding kawalan 
(p<0.05). Aras transkripsi LEP dan miR-192 adalah lebih rendah secara signifikan bagi kumpulan yang dirawat dengan 
fruktosa berbanding kawalan (p<0.05). Terdapat hubungan linear yang signifikan antara aras LEP tisu prostat dengan 
aras LDL/VLDL serum (p<0.05) dan antara aras LEP tisu prostat dengan aras kolesterol total dalam serum (p<0.05). 
Dengan itu, kajian ini menunjukkan bahawa pengambilan fruktosa untuk tempoh yang lama mengurangkan ekspresi 
LEP dan miR-192 pada tisu prostat serta menggalakkan pengumpulan lemak pada tisu. Malah, ekspresi miR-192 
yang rendah dilaporkan mempunyai kaitan dengan patogenesis kanser prostat. Maka, dapat disimpulkan bahawa 
diet fruktosa jangka panjang boleh mengakibatkan peningkatan aras gula dalam darah dan mengurangkan ekspresi 
LEP dan miR-192 pada tisu prostat.
Kata kunci: Fruktosa; leptin; miR-192; keobesan; pengambilan kronik; prostat
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INTRODUCTION
Fructose is a ketonic monosaccharide that is absorbed 
directly into the bloodstream in the digestive tract and it 
can be found in various edible plants (Rumussen 1992). 
Lots of food products are added with fructose for its sweet 
taste, such as high-fructose corn syrup. Even though 
fructose can be a taste enhancer for many processed 
food, but excessive fructose consumption may cause type 
2 diabetes (Kolderup & Svibus 2015), development of 
visceral adiposity, elevation of low density lipids (LDL) 
cholesterol and triglycerides (Bursac et al. 2014), obesity 
(Bocarsly et al. 2010) and increased risk of cardiovascular 
disease (Johnson et al. 2007).
 Fructose metabolism occurs rapidly in the liver, 
producing glyceraldehyde and dihydroxyacetone 
phosphate that later congregates with the glycolytic 
pathway (Basciano et al. 2005). Thus, even though 
glucose consumption is low, fructose can always enter 
the glycolytic pathway and produce glucose, glycogen, 
lactate and pyruvate, which promoting the overproduction 
of triglycerides via de novo lipogenesis and subsequently 
leads to obesity (Kolderup & Svihus 2015).
 Apart from obesity, fructose intake may have effects 
on the regulation of leptin. Leptin is a circulating hormone 
encoded by LEP gene (MIM 164160), secreted by white 
adipocytes. Under normal condition, adipose tissue 
produces leptin to suppress appetite and regulate food 
intake. Thus, leptin plays a key role in regulating body 
weight. As body weight and fat mass rise, the level of leptin 
in plasma proportionately increases (Li 2011). In an in vitro 
study of prostate cancer, high level of leptin in a long-
term period was presented to augment the proliferation 
of prostate cancer cell lines namely LNCaP, DU145 and 
PC-3 by stimulating cell survival pathways (Noda et al. 
2015), triggering proliferation as well as angiogenesis 
(Frankenberry et al. 2004). 
 Another factor that was reported to link with 
obesity is 11β-hydroxysteroid dehydrogenase type 1 
(11β-HSD1) (Aida Azlina et al. 2009; Paulsen et al. 2007). 
It is a reductase enzyme encoded by hydroxysteroid 
11β-dehydrogenase 1 (HSD11B1) gene [MIM 600713]. 
HSD11B1 is highly expressed in key metabolic tissues 
like liver and adipose tissue (Aida Azlina et al. 2009; Lee 
et al. 2013). Its function is to catalyse the inactivation 
cortisol into cortisone (Sjostrand et al. 2010). As a 
result, overexpression of HSD11B1 could lead to the 
accumulation of active cortisol in tissues, which is the 
main glucocorticoid in tissue and subsequently promoting 
visceral adiposity (Spencer & Tilbrook 2011). 
 Previously, reports also showed that obesity is also 
associated with the up-regulation of angiopoietin 1 gene 
(ANGPT1) that involves in anti-apoptosis, cell growth and 
differentiation (Ribeiro et al. 2012). ANGPT1 protein was 
not only expressed in adipose tissues, it has also been found 
in both prostate tumour cells and its capillaries, in which 
it worked as a sprouting angiogenesis inducer (Satoh et al. 
2008).
 To understand the regulation of genes related to 
obesity, we included epigenetic roles in particular 
microRNA (miRNA). There are several miRNAs that involved 
in obesity (Azmir et al. 2014; Chartoumpekis et al. 2012; 
Dehwah et al. 2012; Viesti et al. 2014; Williams & Mitchell 
2012) and cancer development (Ibrahim et al. 2015) 
including miR-10b, miR-34a and miR-192 (Khella et al. 
2013; Senanayake et al. 2012; Sun et al. 2016). These small 
non-coding RNAs work by regulating the expression of their 
target genes in adipocytes and consequently influence the 
differentiation of adipocytes (Arner & Kulyte 2015).
 Numerous dietary approaches in an animal model 
have been shown to induce metabolic syndrome which is 
characterized by obesity, hyperlipidaemia, hypertension 
and increased risk of cardiovascular disease (Mamikutty 
et al. 2014; Wong et al. 2016). 
 In the present in vivo study, we investigated the effect 
of long-term fructose consumption in an animal model 
(Mamikutty et al. 2014) on the biochemical changes and 
genes related to obesity including LEP, HSD11Β1, ANGPT1, 
miR-34a, miR-10b and miR-192 in the peripheral blood 
and prostate tissues.
MATERIALS AND METHODS
STUDY DESIGN
This study was approved by Universiti Kebangsaan 
Malaysia Animal Ethics Committee (UKMAEC) (reference 
no: FP/FISIO/2013/NORHAZLINA/25-SEPT./530-SEPT.-2013-
MAY-2016). A total of 18 male Wistar rats weighted 
between 200 – 250 g were divided into two groups, 
consisted of 9 rats each. The treatment group was given 
20% D-fructose in drinking water, while the control group 
was given distilled water, for six months (Mamikutty 
et al. 2014). Both groups received normal rat pallet ad 
libitum. Each rat was kept in a separate cage in a well-
ventilated room at 22°C with 12 h light and dark cycle. 
Body weight, blood pressure and food consumptions 
were first measured prior to the treatment followed by 
weekly monitoring until before they were sacrificed. 
After six months of treatment, the rats were sacrificed 
under anaesthesia by maximal bleeding through cardiac 
puncture after 6 h fasting. 
SAMPLE COLLECTION
Blood was collected in plain tubes and was placed at room 
temperature for 2 h before being centrifuged at 8000 × g 
and serum was then collected. Prostate tissues were cut and 
divided into several parts (for ELISA and RNA extraction) 
before being snapped freeze and stored in -80°C for further 
analysis. 
FASTING BLOOD GLUCOSE DETERMINATION
After 6 h of fasting, a blood sample was collected to 
determine fasting blood glucose using Accu Check 
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Performa glucometer (Roche, US). The blood glucose level 
was presented in mg/dL.
QUANTITATIVE COLORIMETRIC ASSAY
The level of total cholesterol, triglycerides, high-
density lipoprotein (HDL) and low-density lipoprotein/
very low-density lipoprotein (LDL/VLDL) level in serum 
were determined using quantitative colorimetric assay 
(BioAssay Systems, USA) following manufacturer’s 
protocol. Only non-haemolysed serum observed by 
yellowish fluid was used in this assay. Optical density (OD) 
reading was done at 570 nm. The total cholesterol, HDL 
and LDL/VLDL concentration (mg/dL) were then calculated 
by normalizing the sample’s and standard’s OD reading 
with the blank’s OD reading. The normalized sample’s OD 
reading was then divided with the normalized standard’s 
OD reading and multiplied by 100.
ENZYME-LINKED IMMUNOSORBENT ASSAY
An enzyme-linked immunosorbent assay (ELISA) was 
performed to measure the concentration of 11β-HSD1 and 
leptin in both serum and prostate tissue employing Rat 
Leptin ELISA Kit and Rat 11β-HSD1 ELISA Kits. Tissue 
samples were rinsed in ice-cold PBS (0.01M, pH7.4) to 
eliminate blood thoroughly and were cut into small pieces. 
Tissues were weighed and then homogenized in PBS with a 
glass homogenizer on ice. The PBS volume used was 1 mL 
for 100 mg tissue. The suspension was subjected to four 
times of freeze and thaw cycles to break the cell membrane. 
The homogenates were then centrifuged for at 5000 × g 
for 5 min before the supernatant was collected.
 Serial dilutions of standard were included in each run, 
ranging from 0, 0.156, 0.313, 0.625, 1.25, 2.5, 5, up to 10 
ng/mL. The ELISA for both leptin and 11β-HSD1 were done 
based on the assay protocols provided. The optical density 
(OD) was measured spectrophotometrically at a wavelength 
of 450 nm.
QUANTITATIVE PCR (qPCR) FOR HSD11Β1, LEP, ANGPT1
Total RNA was isolated from a prostate tissue sample using 
miRNeasy Mini kit (Qiagen). Then, the extracted total 
RNA was converted into cDNA using Quantinova cDNA 
conversion kit (Qiagen) following manufacturer’s protocol. 
Subsequently, qPCR was used to relatively quantify the 
expression of HSD11Β1, LEP and ANGPT1 genes. All 
results will be normalized with hypoxanthine guanine 
phosphoribosyl transferase (HPRT) as the housekeeping 
gene. The initial activation step was set at 95oC for 15 
min., followed by 40 cycles of denaturation at 95oC for 
15 min, annealing at 55oC for 30 s and extension at 72oC 
for 30 s. The fold changes were calculated using the ΔΔCt 
comparative quantification method. Fold change of more 
than 1 indicates up-regulation, whereas a fold change of 
less than 1 indicates down-regulation (Chartoumpekis et 
al. 2012).
QUANTITATIVE PCR FOR miR-10b, miR-34a AND miR-192
For miRNA expression study, total RNA was changed into 
cDNA using miScript II RT kit (Qiagen). The expression 
of miRNAs that include rno-miR-10b, rno-miR34a and 
rno-miR-192 were also relatively quantified using qPCR. 
For miRNA expression study, RNU6 was used as the 
housekeeping gene. The initial activation step was set at 
95oC for 15 min., followed by 40 cycles of denaturation 
at 95°C for 15 s, annealing at 55°C for 30 s and extension 
at 70°C for 30 s. The results were calculated as a 2-ΔΔCt 
method (Chartoumpekis et al. 2012).
STATISTICAL ANALYSIS
Statistical Package for the Social Sciences (SPSS) Software 
version 20.0 was used for statistical analysis. Data were not 
normally distributed, hence non-parametric tests were used 
to compare between study groups. Wilcoxon Signed Rank 
Test was used to compare body weight and blood pressure 
before and after six months of fructose treatment in both 
control and fructose treated groups respectively. The 
differences of body weight, blood pressure, biochemical 
parameters and gene as well as microRNA expression 
between control and treated groups were analysed using 
Mann-Whitney U Test. Simple linear regression analysis 
was utilized to explore the relationship between two 
numerical variables. A p value of less than 0.05 was 
regarded as statistically significant.
RESULTS
Body weight and blood pressure of each rat were measured 
before and after six months of fructose treatment (Table 
1). A significant increase in body weight was observed 
in both control and fructose-treated rats group (p<0.05). 
However, an increase in systolic blood pressure was seen 
only in the fructose-treated group (p<0.05). 
 Subsequently, the changes in the body weight and 
blood pressure were compared between the control and 
fructose-treated groups (Table 1). Median body weight 
of the control group (558.2 ± 77.58 g) was observed to 
be higher than the fructose-treated group (501.0 ± 59.00 
g) but statistically, it was not significant. There was no 
statistically significant difference between the median 
changes in systolic blood pressure among the fructose-
treated group (124.0 ± 15.36 mmHg) as compared to the 
control group (121.0 ± 19.11 mmHg). A similar result 
was observed in the median change in the diastolic blood 
pressure among the fructose treated group (90.5 + 20.93 
mmHg) as compared to the control group (78.0 ± 15.09 
mmHg) (Table 1).
 Comparing blood biochemical parameters of both 
groups following 6 months of treatment, only blood 
glucose level in fructose group showed significantly 
increased (p<0.05) (Table 2). No significant effect of 
fructose treatment was observed in 11β-HSD1, leptin and 
lipid profile levels as compared to the control group. 
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 Interestingly, even though there were no significant 
changes in blood levels of 11β-HSD1, leptin and 
triglyceride, the expression of LEP and miR-192 of the 
fructose-treated group were lower compared to the control 
(p<0.05) (Table 3).
 The results from simple linear regression analysis 
showed a linear relationship between LEP and LDL/VLDL 
level (Figure 1) (b=0.05, 95% CI 0.024, 0.076, p=0.002). 
This indicated that for every increase in the LEP level, 
there was an increase in the level of LDL/VLDL. A similar 
trend was observed between LEP and total cholesterol level 
whereby there was also a significant linear relationship 
between these two parameters (Figure 2) (b=0.031, 95% 
CI 0.004, 0.058, p=0.027).
DISCUSSION
Chronically, fructose consumption leads to obesity, insulin 
resistance, type 2 diabetes mellitus and hypertension 
(Kolderup & Svihus 2015; Lakhan & Kirchgessner 2013; 
Mamikutty et al. 2014). Fructose has the same chemical 
formula as glucose and readily absorbed in the gut via 
facilitated diffusion. Metabolism of fructose differs from 
that of glucose, where it is rapidly converted into glucose, 
glycogen, lactate, and fat in the liver. Our study adopted 
animal model established by Mamikutty et al. (2014). In 
the present study, 20% fructose treatment for a period of 
six months did not lead to significant differences in body 
weight and lipid profile when compared to the control 
TABLE 2. Biochemical parameters of the rats treated with fructose and control groups (n=9) 
Median (SD) P valueControl Fructose Treated
Blood glucose (mg/dL)
11β-HSD1 ng/mL
Leptin ng/mL
Triglyceride (mg/dL)
Total cholesterol (mg/dL)
HDL (mg/dL)
LDL/VLDL (mg/dL)
11.10 (2.33)
5.29 (5.29)
1.00 (0.51)
60.50 (23.23)
99.66 (15.78)
37.15 (14.91)
17.17 (8.59)
14.50 (6.34)
4.15 (4.56)
1.15 (0.68)
61.53 (54.23)
83.14 (21.67)
33.05 (4.24)
18.56 (17.72)
0.030*
0.337
1.000
1.000
0.748
0.749
0.262
Data are shown as median (standard deviation, SD)
*p<0.05 median blood glucose levels of the fructose-treated group were significantly increased compared to control group after a 6-month treatment
TABLE 1. Body weight and blood pressure measurement of pre- and post-treatment of rats with fructose diet and control groups 
Control (n=9)
Median (SD)
Treated (n=9)
Median (SD)
Month 0 Month 6 P-value Month 0 Month 6 P-value
Body weight (g) 209.3 (28.59) 558.2 (77.58) 0.008a 202.2 (40.52) 501.5 (59.00) 0.008a
Blood pressure: 
Systolic (mmHg)
Diastolic (mmHg)
127.0 (26.69)
86.0 (24.94)
121.0 (19.11)
78.0 (15.09)
0.953
0.859
112.5 (18.95)
78.0 (16.41)
124.0 (15.36)
90.5 (20.93)
0.025a
0.237
Data are shown as median (standard deviation, SD)
ap<0.05 median body weights and systolic blood pressure were significantly increased compared to before treatment
TABLE 3. Concentration of 11β-HSD1, leptin, triglyceride and expression levels of HSD11B1, LEP, ANGPT1, 
miR-10b, miR-34a and miR-192 in fructose-treated and control groups after a 6-month treatment 
Median (SD) P valueControl Treated
11β-HSD1 
Leptin
Triglyceride 
HSD11Β1
LEP
ANGPT1
miR-10b
miR-34a
miR-192
12.8 (3.27) ng/mL
0.45 (0.13) ng/mL
90.28 (51.56) ng/mL
1 (0)
1 (0)
1 (0)
1 (0)
1 (0)
1 (0)
10.94 (4.76) ng/mL
0.33 (0.19) ng/mL
155.28 (112.56) ng/mL
0.85 (0.64)
0.55 (1.11)
0.92 (0.31)
0.94 (0.77)
1.07 (12.51)
0.45 (0.40)
0.596
0.134
0.211
1.000
0.009*
0.348
0.383
0.671
0.004*
Data are shown as median (standard deviation, SD).
*p<0.05 Expression of LEP gene and miR-192 were down-regulated in fructose-treated group compared to control after a 6-month treatment
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group. This finding is in agreement with Bursac et al. 
(2014), in which differences in the body weight of the 
fructose-treated group (male Wistar rats, treated with 60% 
fructose over 9 weeks) when compared to the control was 
not significant. Bursac et al. (2014) also reported that there 
was a statistically higher level of triglycerides and leptin 
concentration in the fructose treated group but with no 
significant differences in blood glucose level as compared 
to the control. Thus, it can be postulated that higher fructose 
intake is associated with more accumulation of visceral fat. 
In 2008, the Third National Health and Nutrition 
Examination Survey showed that 10% of daily calories 
intake came from fructose. Thus, compared to the study 
by Bursac et al. (2014), a lower percentage of fructose 
diet (20%) was chosen in the present study. Choosing 
an inflated (60%) fructose diet as in Bursac et al. (2014) 
study does not mimic the real-life situation although it is 
not impossible. Furthermore, adding 60% of fructose in 
daily meals seems to be very unusual.
 In the existing study, even though there were no 
significant alterations in physical and biochemical 
parameters between both treated and untreated groups, 
significant changes were found at the molecular level. 
Interestingly, after six months of intervention, no 
significant changes were observed in circulating leptin, 
however, mRNA level of LEP in the prostate tissue was 
considerably lower in the fructose-treated group as 
compared to the control. Elevated leptin level was observed 
in plasma samples after two months of 60% fructose 
treatment (Bursac et al. 2014). Under normal condition, 
LEP is expressed to suppress appetite when an individual 
has already consumed sufficient amount of food. Thus, in 
the present study, significantly lower LEP expression in the 
fructose-treated group showed that long-term (six months) 
fructose diet could dysregulate the expression of key genes 
at the mRNA level in glucose and lipid metabolism pathway, 
thus promoting to the progression of metabolic syndrome. 
This is because LEP was reported to play a key role in the 
development of obesity and somatic mutation or variant 
in LEP was linked with early-onset obesity (Saeed et al. 
2015; Shabana & Shahida 2016). 
 LEP expression level was further analyzed and a 
significant linear relationship between prostate LEP and 
serum LDL/VLDL level as well as between prostate LEP and 
serum total cholesterol level were discovered. Thus, our 
results showed that long-term fructose diet could down-
regulate the expression of LEP in prostate tissue leading to 
the accumulation of fat higher in prostate tissue compared 
to the blood circulation.
 Apart from LEP mRNA level, the miR-192 expression 
level in prostate tissue was also significantly reduced 
in the fructose-treated group than in control group. 
In concordance with our finding, reduced miR-192 
expression was also detected in the development of obesity 
(Chartoumpekis et al. 2012). The involvement of miR-192 
in obesity can be explained through its target genes, zinc 
finger E-box (zeb1 and zeb2) that have been associated 
with adipogenesis and obesity (Saykally et al. 2009). More 
alarmingly, there were also previous studies that reported 
the association between the down-regulation of miRNA-192 
with cancer development (Khella et al. 2013; Senanayake 
et al. 2012) including prostate cancer (Sun et al. 2016). 
Thus, our finding showed that long-term fructose diet could 
dysregulate miR-192 in the prostate with the possibility to 
cause not only obesity but also increase the risk of prostate 
cancer development.
CONCLUSION
Chronic fructose consumption may lead to downregulation 
of the mRNA level of LEP and miR-192 in prostate tissue. 
Thus, it can be postulated that a longer duration of fructose 
diet leads to prostate adiposity and consequently increase 
the risk of prostate cancer. Further functional study of the 
targeted genes is required to confirm this hypothesis.
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